1. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Psychother Psychosom. 2009;78(5):265–74. [
DOI]
2. Ciechanowski P, Walker EA, Katon W. Attachment theory and somatization: an integrative review. Psychosom Med. 2002;64(6):660–7. [
DOI]
3. Brown RJ. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull. 2004;130(5):793–812. [
DOI]
4. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881–8. [
DOI]
5. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric co‐morbidity and management. Int J Methods Psych Res. 2003;12(1):34–43. [
DOI]
6. Wortman MSH, Van Der Wouden JC, Twisk JWR, Visser B, Assendelft WJJ, Van Der Horst HE, et al. Effectiveness of psychosomatic therapy for patients with persistent somatic symptoms: Results from the CORPUS randomised controlled trial in primary care. J Psychosom Res. 2023;167:111178. [
DOI]
7. Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res. 2004;56(4):391–408. [
DOI]
8. Henningsen P, Gündel H, Kop WJ, Löwe B, Martin A, Rief W, et al. Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom Med. 2018;80(5):422–31. [
DOI]
9. Henningsen P. Still modern? developing the biopsychosocial model for the 21st century. J Psychosom Res. 2015;79(5):362–3. [
DOI]
10. De Gucht V, Maes S. Explaining medically unexplained symptoms: toward a multidimensional, theory-based approach to somatization. J Psychosom Res. 2006;60(4):349–52. [
DOI]
11. Leichsenring F. Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA. 2008;300(13):1551. [
DOI]
12. Abbass A, Haghiri B. Intensive short-term dynamic psychotherapy for functional somatic disorders: a scoping review. Clin Neuropsychiatry. 2025;22(2):111–20. [
DOI]
13. Kirmayer LJ, Young A. Culture and somatization: clinical, epidemiological, and ethnographic perspectives. Psychosom Med. 1998;60(4):420–30. [
DOI]
14. Lane RD, Weihs KL, Herring A, Hishaw A, Smith R. Affective agnosia: expansion of the alexithymia construct and a new opportunity to integrate and extend Freud’s legacy. Neurosci Biobehav Rev. 2015;55:594–611. [
DOI]
15. Wortman MSH, Olde Hartman TC, Van Der Wouden JC, Dankers S, Visser B, Assendelft WJJ, et al. Perceived working mechanisms of psychosomatic therapy in patients with persistent somatic symptoms in primary care: a qualitative study. BMJ Open. 2022;12(1):e057145. [
DOI]
16. Torp NC, Højgaard DR, Aalberg M, Hybel KA, Skarphéðinsson GÁ, Thomsen PH, et al. The role of treatment expectations in predicting treatment outcomes: examining clinical and demographic influences. Nord J Psychiatry. 2025;79(6):462–71. [
DOI]
17. Sharpe M, Carson A. “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med. 2001;134(9):926–30. [
DOI]
18. Kapos FP, Hoeger Bement M, Sluka KA. Social determinants and consequences of pain. J Pain. 2024;25(5):e145–e158.
19. Lumley MA, Schubiner H. Emotional awareness and expression therapy for chronic pain: rationale, principles and techniques, evidence, and critical review. Curr Rheumatol Rep. 2019;21(7):30. [
DOI]
20. Uchino BN. Social support and health: a review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006;29(4):377–87. [
DOI]